Sage Journals: Discover world-class research

Abstract

Keywords

Botulinum toxin Detrusor injection Paralysis Neurotoxicity Overactive bladder

Get full access to this article

View all access options for this article.

References

Dolly

. Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins. Headache 2003;43(Suppl 1):S16–24.

Grosse

Kramer

Stohrer

. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 2005;47:653–9.

De Laet

Wyndaele

. Adverse events after botulinum A toxin injection for neurogenic voiding disorders. Spinal Cord 2005;43:397–9.

Jeffery

Fynes

Lee

Wang

Williams

Morley

. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 2007;100:1302–6.

Ruffion

Capelle

Paparel

Leriche

Grise

. What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int 2006;97:1030–4.

Wiegand

Erdmann

Wellhoner

. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1976;292:161–5.

Paraplegia as a Complication of Intravesical Botulinum Toxin A (Dysport®) Injection for Overactive Bladder

Abstract

Keywords

Get full access to this article

References